Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Schulmann

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|July 31, 2021
Early detection of duodenal cancer by upper gastrointestinal-endoscopy in Lynch syndromeDeepak B Vangala, Swetlana Ladigan-Badura, Christoph Engel, et al.
International Journal of Cancer|September 15, 2020
Value of upper gastrointestinal endoscopy for gastric cancer surveillance in patients with Lynch syndromeSwetlana Ladigan-Badura, Deepak B Vangala, Christoph Engel, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Cancer Letters|July 16, 2008
Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German familiesBernd Frank, Barbara Burwinkel, Justo Lorenzo Bermejo, et al.
Carcinogenesis|July 9, 2010
Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibilityJesús Lascorz, Asta Försti, Bowang Chen, et al.
International Journal of Cancer|June 2, 2004
Prevalence of familial pancreatic cancer in GermanyDetlef K Bartsch, Ralf Kress, Mercedes Sina-Frey, et al.
Gastroenterology|August 1, 2018
No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance PoliciesChristoph Engel, Hans F Vasen, Toni Seppälä, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Gastroenterology|January 12, 2020
Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch SyndromeChristoph Engel, Aysel Ahadova, Toni T Seppälä, et al.
Lancet (London, England)|April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|July 31, 2021
Early detection of duodenal cancer by upper gastrointestinal-endoscopy in Lynch syndromeDeepak B Vangala, Swetlana Ladigan-Badura, Christoph Engel, et al.
International Journal of Cancer|September 15, 2020
Value of upper gastrointestinal endoscopy for gastric cancer surveillance in patients with Lynch syndromeSwetlana Ladigan-Badura, Deepak B Vangala, Christoph Engel, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Cancer Letters|July 16, 2008
Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German familiesBernd Frank, Barbara Burwinkel, Justo Lorenzo Bermejo, et al.
Carcinogenesis|July 9, 2010
Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibilityJesús Lascorz, Asta Försti, Bowang Chen, et al.
International Journal of Cancer|June 2, 2004
Prevalence of familial pancreatic cancer in GermanyDetlef K Bartsch, Ralf Kress, Mercedes Sina-Frey, et al.
Gastroenterology|August 1, 2018
No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance PoliciesChristoph Engel, Hans F Vasen, Toni Seppälä, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Gastroenterology|January 12, 2020
Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch SyndromeChristoph Engel, Aysel Ahadova, Toni T Seppälä, et al.
Lancet (London, England)|April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Pageof 5